- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Kabra Drugs Limited's Board of Directors has approved a change in its Chief Financial Officer (CFO). Mr. T. Pavanasam has been appointed as the new CFO and Key Managerial Personnel, effective immediately. He brings over 15 years of experience in finance and taxation across various industries. Concurrently, Mr. Bangalore Venkatakrishnappa Ananth Kumar has resigned from the CFO position, also effective immediately. This leadership transition is important for the company's financial oversight and management.